A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence

Phase 2 Completed 156 enrolled University of Pennsylvania

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a double-blind placebo-controlled clinical trial (n = 156) of varenicline for the treatment of cocaine dependence that utilizes contingency management to promote treatment attendance.

Timeline

Start: 2012-08
Primary completion: 2018-01
Completion: 2019-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Varenicline	Small molecule	1 mg	Oral

A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence

Summary

Timeline

Drugs

Indications